Antitumor effect of interferon-on U937 human acute leukemia cells in vitro and its molecular mechanism

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 27, Issue 5, 2007, Pages 513-515

  Zhang, Chun ^a   Cui, Guohui ^a   Chen, Yan ^a   Fan, Ke ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute leukemia; Apoptosis; Cyclin E; Interferon

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CYCLIN E;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN U937; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CYCLIN E; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON-ALPHA; U937 CELLS;

EID: 36849021008     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-007-0509-z     Document Type: Article

References (9)

1. Leclere S, Myers R P, Mousalli J et al. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med, 2003,14(4):237-243
2. Liedtke C, Groger N, Manns M P et al. Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells. J Hepatol, 2006,44(2):342-349
3. Taylor K L, Oates R K, Grane R et al. IFN-alphal, 8 inhibits tumor-induced angiogenesis in murine angiosarcomas. J Interferon Cytokine Res, 2006,26(5):353-361
4. Lehtonen A, Lund R, Lahesmaa R et al. IFN-alpha and IL-12 activate IFN regulatory factor 1 (IRF-1), IRF-4, and IRF-8 gene expression in human NK and T cells. Cytokine, 2003,24(3):81-90
5. Kelly J D, Dai J, Eschwege P et al. Down-regulation of Bel-2 sensitizes interferon-resistant renal cancer cells to Fas. Br J Cancer, 2004,91(1):164-170
6. Aleem E, Kiyokawa H, Kaldis P et al. Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol, 2005,7(8):831-836
7. Lundberg A S, Weiberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol, 1998,18(11):753-762
8. Rosen D G, Yang G, Deavers M T et al. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma. Cancer, 2006,106(9):1925-1932
9. Lida H, Towaltari M, Tanmoto M et al. Overexpression of cyclin E in acute myelogenous leukemia. Blood, 1997,11(9):3707-3713